SAM
GSK icon

Sunnymeath Asset Management’s GSK GSK Stock Holding History

Sunnymeath Asset Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$31K Sell
640
-18,480
-97% -$913K 0.04% 112
2016
Q3 		$743K Sell
19,120
-416
-2% -$22.8K 1.63% 22
2016
Q2 		$1.06M Buy
19,536
+11,136
+133% +$587K 1.55% 22
2016
Q1 		$424K Sell
8,400
-11,840
-58% -$590K 0.65% 55
2015
Q4 		$1.02M Buy
+20,240
New +$1.03M 1.63% 22

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sunnymeath Asset Management's GSK Position: Q4 2016 in Review

Sunnymeath Asset Management reduced its GSK (GSK) stake by 97% in Q4 2016, selling an estimated $913K and leaving 640 shares worth $31K. The position accounts for 0.04% of the portfolio, ranked #112.

Sunnymeath Asset Management first reported a position in GSK in Q4 2015 and has held it in 5 quarters since. The position peaked at $1.06M in Q2 2016. 762 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

  • Sunnymeath Asset Management held 640 shares of GSK worth $31K as of Q4 2016.
  • Sunnymeath Asset Management sold 18,480 GSK shares in Q4 2016, an estimated $913K.
  • GSK made up 0.04% of Sunnymeath Asset Management's portfolio in Q4 2016, its #112 holding.
  • Sunnymeath Asset Management first reported a position in GSK in Q4 2015 and has held it in 5 quarters since.
  • Sunnymeath Asset Management's GSK position peaked at $1.06M in Q2 2016.
  • 762 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on Sunnymeath Asset Management's 13F filing for Q4 2016, filed 13 Jan 2017.